JP2023500480A5 - - Google Patents
Info
- Publication number
- JP2023500480A5 JP2023500480A5 JP2022525094A JP2022525094A JP2023500480A5 JP 2023500480 A5 JP2023500480 A5 JP 2023500480A5 JP 2022525094 A JP2022525094 A JP 2022525094A JP 2022525094 A JP2022525094 A JP 2022525094A JP 2023500480 A5 JP2023500480 A5 JP 2023500480A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- heavy chain
- light chain
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025131369A JP2025170788A (ja) | 2019-11-01 | 2025-08-06 | 癌の治療のための抗ｃｄ２７抗体の投薬計画 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962929538P | 2019-11-01 | 2019-11-01 | |
| US62/929,538 | 2019-11-01 | ||
| PCT/US2020/057817 WO2021087016A1 (en) | 2019-11-01 | 2020-10-29 | Dosing regimen of anti-cd27 antibodies for treatment of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025131369A Division JP2025170788A (ja) | 2019-11-01 | 2025-08-06 | 癌の治療のための抗ｃｄ２７抗体の投薬計画 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500480A JP2023500480A (ja) | 2023-01-06 |
| JP2023500480A5 true JP2023500480A5 (cg-RX-API-DMAC10.html) | 2023-11-08 |
Family
ID=75716307
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525094A Pending JP2023500480A (ja) | 2019-11-01 | 2020-10-29 | 癌の治療のための抗ｃｄ２７抗体の投薬計画 |
| JP2025131369A Withdrawn JP2025170788A (ja) | 2019-11-01 | 2025-08-06 | 癌の治療のための抗ｃｄ２７抗体の投薬計画 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025131369A Withdrawn JP2025170788A (ja) | 2019-11-01 | 2025-08-06 | 癌の治療のための抗ｃｄ２７抗体の投薬計画 |
Country Status (10)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240004937A (ko) | 2021-05-05 | 2024-01-11 | 이매틱스 바이오테크놀로지스 게엠베하 | Bma031 항원 결합 폴리펩타이드 |
| WO2025188553A1 (en) * | 2024-03-05 | 2025-09-12 | Merck Sharp & Dohme Llc | Methods and compositions for treatment of cancer with anti-cd27 antibodies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2804550C (en) * | 2010-07-09 | 2021-01-05 | Bionovion Holding B.V. | Agonistic antibody to cd27 |
| US10392442B2 (en) * | 2015-12-17 | 2019-08-27 | Bristol-Myers Squibb Company | Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment |
| JOP20190055A1 (ar) * | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
-
2020
- 2020-10-29 EP EP20881154.7A patent/EP4051712A4/en not_active Withdrawn
- 2020-10-29 WO PCT/US2020/057817 patent/WO2021087016A1/en not_active Ceased
- 2020-10-29 JP JP2022525094A patent/JP2023500480A/ja active Pending
- 2020-10-29 CA CA3159366A patent/CA3159366A1/en active Pending
- 2020-10-29 US US17/772,229 patent/US20230192876A1/en not_active Abandoned
- 2020-10-29 BR BR112022008233A patent/BR112022008233A2/pt unknown
- 2020-10-29 CN CN202080084116.1A patent/CN114761432A/zh active Pending
- 2020-10-29 MX MX2022005245A patent/MX2022005245A/es unknown
- 2020-10-29 KR KR1020227018204A patent/KR20220092569A/ko not_active Withdrawn
- 2020-10-29 AU AU2020372912A patent/AU2020372912A1/en active Pending
-
2025
- 2025-08-06 JP JP2025131369A patent/JP2025170788A/ja not_active Withdrawn